Skip to content
OpenCapital
Get started

Jabil JBL Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
Foreign source revenue75.8%+4.6%

Other financials

Income statement

See full
Revenue$8.8B+11.8%
Gross profit$828.0M+21.6%
Operating income$445.0M+10.4%
Net income$275.0M+23.9%
EPS (diluted)$2.59+27.6%

Balance sheet

See full
Cash & equivalents$1.4B-10.7%
Total debt$3.9B+16.9%
Total equity$1.3B+3.0%
Total assets$23.8B+28.1%

Cash flow

See full
Operating cash flow$535.0M+31.8%
CapEx$184.0M+114%
Free cash flow$351.0M+9.7%

Valuation

See full
Market cap$40.67B+76.5%
Enterprise value$43.2B+63.6%
P/E47.2×+7.3×
P/S1.2×+0.4×

Profitability

See full
Gross margin9.2%+0.4pp
Operating margin4.3%+0.2pp
Net margin2.6%+0.5pp
FCF margin3.9%-0.7pp

Returns & leverage

See full
Return on equity66.1%+33.7pp
Debt / equity3.3×+0.8×
Current ratio1×0.0×